glucose, (beta-d)-isomer has been researched along with Arteriosclerosis, Coronary in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 15 (68.18) | 2.80 |
| Authors | Studies |
|---|---|
| Connelly, KA; Deva, DP; Ge, Y; Jimenez-Juan, L; Mazer, CD; Ng, MY; Pourafkari, M; Quan, A; Rai, A; Ramanan, V; Roifman, I; Teoh, H; Verma, S; Yan, AT | 1 |
| Ma, F; Wang, H; Wu, Y; Zhang, J | 1 |
| Fang, DM; Guo, YJ; Li, Y; Liang, ZF; Liu, YL; Miao, L; Tao, L; Yang, ZJ | 1 |
| Al-Omran, M; Bhatt, DL; Connelly, KA; Dhingra, N; Hess, DA; Leiter, LA; Mason, T; Mazer, CD; Quan, A; Rotstein, OD; Sabongui, S; Teoh, H; Terenzi, DC; Trac, JZ; Verma, S; Yan, AT; Zinman, B | 1 |
| Hashimoto, N; Kawai, H; Ohara, T; Onishi, T; Sawada, T; Shimane, A; Takaya, T; Taniguchi, Y; Uzu, K; Yasaka, Y | 1 |
| Connelly, KA; Connelly, PW; Gilbert, RE; Goldenberg, RM; Hare, GMT; Jüni, P; Leiter, LA; Mazer, CD; Mistry, N; Quan, A; Shehata, N; Teoh, H; Thorpe, KE; Verma, S; Yan, AT; Zinman, B; Zuo, F | 1 |
| Petrie, MC | 1 |
| Agra-Bermejo, RM; Couselo-Seijas, M; Eiras, S; Fernández, AL; González-Juanatey, JR; Martínez-Cereijo, JM; Rozados-Luis, A; Sierra, J; Soto-Pérez, M | 1 |
| Cumhur Cure, M; Cure, E | 1 |
| Aizawa, Y; Fujita, S; Ikeda, Y; Okabe, M; Sato, T; Yuasa, S | 1 |
| Tsuda, K | 1 |
| Bami, K; Connelly, KA; Gandhi, S; Garg, V; Gilbert, RE; Ho, E; Jüni, P; Leiter, LA; Leong-Poi, H; Mazer, CD; Ong, G; Quan, A; Teoh, H; Thorpe, KE; Verma, S; Yan, AT; Zahrani, M; Zinman, B; Zuo, F | 1 |
| Hashikata, T; Ikutomi, M; Jimba, T; Kakuda, N; Katsushika, S; Kishi, M; Matsushita, M; Ohnishi, S; Sato, T; Shindo, A; Yamasaki, M; Yokoyama, M | 1 |
| Cheng, XL; Feng, L; Jia, XB; Ke, ZC; Lin, CY | 1 |
| Nabavizadeh, P; Steen, DL | 1 |
| Ahangar, H; Arsang-Jang, S; Dadashi, M; Fathi, M; Ghaffari, S; Ghanbari, S; Gohari, S; Ismail-Beigi, F; Khodabandehloo, H; Muhammadi, MJ; Reshadmanesh, T | 1 |
| Ahn, JM; Choi, JH; Kim, SO; Lee, CW; Lee, PH; Lee, SW; Moon, DH; Oh, M | 1 |
| Bjornstad, P; Cherney, DZI; Lovshin, JA; Lytvyn, Y; Udell, JA | 1 |
| Chattipakorn, N; Chattipakorn, S; Gunaparn, S; Jaiwongkam, T; Kumfu, S; Phrommintikul, A; Wongcharoen, W | 1 |
| Jadhav, A; Prasad, K | 1 |
| Li, Y; Lou, C; Wang, X | 1 |
| Feng, L; Han, X; Hu, S; Jia, X; Song, Y; Wang, R; Zhang, M; Zhang, X; Zhu, M | 1 |
2 review(s) available for glucose, (beta-d)-isomer and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Female; Glucosides; Heart Failure; Hospitalization; Humans; Hypertension; Male; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
Prevention and treatment of atherosclerosis with flaxseed-derived compound secoisolariciresinol diglucoside.
Topics: Animals; Butylene Glycols; Coronary Artery Disease; Disease Models, Animal; Flax; Glucosides; Humans; Phytotherapy; Rabbits | 2016 |
8 trial(s) available for glucose, (beta-d)-isomer and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial.
Topics: Benzhydryl Compounds; Coronary Artery Disease; Diabetes Mellitus, Type 2; Glucosides; Humans; Ventricular Function, Left | 2022 |
Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function.
Topics: Benzhydryl Compounds; Blood Glucose; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents | 2022 |
SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cardiotonic Agents; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Glucosides; Humans; Middle Aged; Myeloid Progenitor Cells; Regeneration; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
The Effect of Dapagliflozin Treatment on Epicardial Adipose Tissue Volume and P-Wave Indices: An Ad-hoc Analysis of The Previous Randomized Clinical Trial.
Topics: Adipose Tissue; Aged; Benzhydryl Compounds; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Male; Middle Aged; Pericardium; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Effects of Empagliflozin on Left Ventricular Remodeling in Patients with Type 2 Diabetes and Coronary Artery Disease: Echocardiographic Substudy of the EMPA-HEART CardioLink-6 Randomized Clinical Trial.
Topics: Benzhydryl Compounds; Coronary Artery Disease; Diabetes Mellitus, Type 2; Echocardiography; Glucosides; Humans; Ventricular Remodeling | 2020 |
Empagliflozin attenuates neointimal hyperplasia after drug-eluting-stent implantation in patients with type 2 diabetes.
Topics: Aged; Benzhydryl Compounds; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Type 2; Drug-Eluting Stents; Female; Glucosides; Humans; Hyperplasia; Japan; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Prospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2020 |
Study rationale and design of a study of EMPAgliflozin's effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial.
Topics: Adult; Aged; Benzhydryl Compounds; Biomarkers; Blood Glucose; Coronary Artery Disease; Diabetes Mellitus, Type 2; Disease Progression; Female; Glucosides; Glycated Hemoglobin; Humans; Inflammation Mediators; Iran; Male; Middle Aged; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome | 2021 |
Effects of dapagliflozin vs vildagliptin on cardiometabolic parameters in diabetic patients with coronary artery disease: a randomised study.
Topics: Aged; Benzhydryl Compounds; Biomarkers; Blood Glucose; Blood Pressure; China; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Humans; Inflammation Mediators; Lipids; Male; Middle Aged; Prospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome; Troponin T; Vildagliptin | 2019 |
12 other study(ies) available for glucose, (beta-d)-isomer and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Mechanism of salidroside against coronary artery disease by network pharmacology analysis.
Topics: Coronary Artery Disease; Glucosides; Humans; Network Pharmacology; Phenols | 2023 |
Empagliflozin's Ameliorating Effect on Plasma Triglycerides: Association with Endothelial Function Recovery in Diabetic Patients with Coronary Artery Disease.
Topics: Benzhydryl Compounds; Body Weight; Cardiometabolic Risk Factors; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias; Endothelium, Vascular; Female; Glucose; Glucosides; Hemodynamics; Humans; Lipid Metabolism; Male; Middle Aged; Outcome Assessment, Health Care; Sodium-Glucose Transporter 2 Inhibitors; Triglycerides | 2020 |
Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
Topics: Benzhydryl Compounds; Coronary Artery Disease; Diabetes Mellitus, Type 2; Erythrocyte Count; Erythrocytes; Erythropoietin; Ferritins; Glucosides; Hematocrit; Humans; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Sodium Glucose Cotransporter 2 Inhibitors: Searching for Mechanisms in the Wake of Large, Positive Cardiovascular Outcomes Trials.
Topics: Benzhydryl Compounds; Coronary Artery Disease; Diabetes Mellitus, Type 2; Glucosides; Humans; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment.
Topics: Adipose Tissue; Benzhydryl Compounds; Coronary Artery Disease; Glucose; Glucosides; Humans; Lactic Acid; Pericardium; Sodium-Glucose Transport Proteins | 2020 |
Comment on: "High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment".
Topics: Benzhydryl Compounds; Coronary Artery Disease; Glucosides; Humans; Lactic Acid | 2020 |
Letter by Tsuda Regarding Article, "Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial".
Topics: Benzhydryl Compounds; Coronary Artery Disease; Diabetes Mellitus, Type 2; Glucosides; Humans | 2020 |
[Characterization of oil/water partition coefficient of chishao terpene glucoside components based on contribution rate of representative components for myocardial ischemia].
Topics: Animals; Coronary Artery Disease; Glucosides; Medicine, Chinese Traditional; Myocardial Ischemia; Rats; Terpenes; Water | 2020 |
Highlights from the European society of cardiology congress 2020.
Topics: Atrial Fibrillation; Benzhydryl Compounds; Benzylamines; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Clinical Trials as Topic; Colchicine; Coronary Artery Disease; Europe; Glucosides; Heart Failure; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Societies, Medical; Sodium-Glucose Transporter 2 Inhibitors; Tubulin Modulators; Uracil | 2021 |
Comparison of empagliflozin and sitagliptin therapy on myocardial perfusion reserve in diabetic patients with coronary artery disease.
Topics: Benzhydryl Compounds; Coronary Artery Disease; Glucosides; Humans; Middle Aged; Myocardial Perfusion Imaging; Sitagliptin Phosphate; Tomography, Emission-Computed, Single-Photon | 2021 |
Gastrodin Pretreatment Impact on Sarcoplasmic Reticulum Calcium Transport ATPase (SERCA) and Calcium Phosphate (PLB) Expression in Rats with Myocardial Ischemia Reperfusion.
Topics: Animals; Benzyl Alcohols; Calcium; Calcium Phosphates; Calcium-Binding Proteins; Coronary Artery Disease; Glucosides; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2016 |
Liquiritin attenuates advanced glycation end products-induced endothelial dysfunction via RAGE/NF-κB pathway in human umbilical vein endothelial cells.
Topics: Antibodies, Monoclonal; Apoptosis; Coronary Artery Disease; Down-Regulation; Flavanones; Glucosides; Glycation End Products, Advanced; Herbal Medicine; Human Umbilical Vein Endothelial Cells; Humans; Malondialdehyde; NF-kappa B; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Signal Transduction; Superoxide Dismutase; Transforming Growth Factor beta1 | 2013 |